Compositions And Methods For Targeted Depletion, Enrichment, And Partitioning Of Nucleic Acids Using Crispr/Cas System Proteins

Patent No. EP3234200 (titled "Compositions And Methods For Targeted Depletion, Enrichment, And Partitioning Of Nucleic Acids Using Crispr/Cas System Proteins") was filed by ARC BIO on Dec 19, 2015. The application was issued on Jul 7, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
JUMPCODE GENOMICSApr 7, 2022J A KEMP

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3234200

ARC BIO
Application Number
EP15871259A
Filing Date
Dec 19, 2015
Status
Granted And Under Opposition
Jun 12, 2021
Publication Date
Jul 7, 2021